Understanding and treating neurological disorders
Welcome to the Department of Neurology and Neurological Sciences at Stanford!
The Department has been a center of excellence for more than four decades and includes over 140 School of Medicine faculty members with primary academic appointments in the Department at our four outstanding teaching hospitals and health care systems. The Stanford Health Care (SHC) new 824,000 square-foot state-of-the-art hospital opened in 2019 with over 600 beds, making it one of the largest inpatient facilities in California. Ranked in the top 10 for Neurology and Neurosurgical Care by US News and World Report, SHC is at the cutting edge of the latest treatments for neurological diseases. SHC boasts a dedicated outpatient Stanford Neuroscience Health Center—a facility like no other on the West Coast—as well as clinics located throughout Northern California. With over 60,000 annual outpatient visits and thus one of the largest neurology volumes in the U.S., Stanford Neurology provides care for a large and highly diverse patient population and supports excellence in clinical care, education, and research.
Paul Graham Fisher, MD
Interim Chair, Department of Neurology and Neurological Sciences
Professor, Neurology, Pediatrics, and by courtesy, Neurosurgery, Epidemiology and Population Health, and Human Biology
The Beirne Family Professor of Pediatric Neuro-Oncology
The Dunlevie Family University Fellow in Undergraduate Education
Depression can be a very serious problem after stroke. This study will help us develop new and better treatments for those who aren't completely treated by current anti-depressants.
Congratulations, Chinyere Agbaegbu Iweka, PhD, on receiving a Simons Foundation Independence Award for her work "Circadian regulation of immune cell metabolism and the effect on cognitive flexibility in the aging brain"
Congratulations, Cellas Hayes, PhD on your 2023 Stanford Postdoc JEDI Champion award! The JEDI Champion Awards are a recognition of current Stanford postdoctoral scholars who have championed initiatives, activities, or efforts that advance justice, equity, diversity, & inclusion at Stanford and beyond.
Lawrence Steinman, MD and his collaborators recently identified a molecule that could be targeted by drug developers to treat ALS. The protein, alpha 5 integrin, is related to another integrin (alpha 4), a type of protein that helps immune cells move and bind to their surroundings like Velcro.
Welcome Anthony Omuro, MD
The Department of Neurology and Neurological Sciences would like to welcome our newly appointed chair, Antonio Omuro, MD, who will join our department in February 2024.
A massive study of medical and genetic data shows that people with a particular version of a gene involved in immune response had a lower risk of Alzheimer’s and Parkinson’s disease.
Which comes first: Depression or dementia? A team of scientists led by Victor Henderson, MD found that the risk of dementia more than doubles for people previously diagnosed with depression.
Congratulations to Juliet Knowles, MD, PhD for receiving a McKnight Foundation 2023 Neurobiology of Brain Disorders Award for her work "Neuron-to-OPC synapses in adaptive and maladaptive myelination"
The Certificate of Special Congressional Recognition
Jeff Dunn, MD was awarded The Certificate of Special Congressional Recognition by Rep. Mike Thompson for advancing the care and research of Multiple Sclerosis.
Congratulations, Yi Li, MD, PhD, for receiving an American Epilepsy Society Junior Investigator Award for her work titled "Genetic impact of women with epilepsy on their children’s cognitive outcome".